Publications by authors named "Francesca Bizzaro"

Claim this Profile
I
Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.
Michela Lupia, Valentina Melocchi, Francesca Bizzaro, Pietro Lo Riso, Elisa Dama

Int J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice.
Sharmila Fagoonee, Maddalena Arigoni, Marta Manco, Martina Olivero, Francesca Bizzaro

Antioxid Redox Signal· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
Francesca Bizzaro, Ilaria Fuso Nerini, Molly A Taylor, Alessia Anastasia, Massimo Russo

J Hematol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.
Francesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, Alessandra Decio, Lucia Minoli

Int J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.
Federica Guffanti, Maddalena Fratelli, Monica Ganzinelli, Marco Bolis, Francesca Ricci, Francesca Bizzaro

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer.
Francesca Falcetta, Francesca Bizzaro, Elisa D'Agostini, Maria Rosa Bani, Raffaella Giavazzi

Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.
Denise Pinessi, Paola Ostano, Patrizia Borsotti, Ezia Bello, Federica Guffanti, Francesca Bizzaro

Connect Tissue Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics.
Ilaria Fuso Nerini, Marta Cesca, Francesca Bizzaro, Raffaella Giavazzi

Chin J Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.
Alessandra Decio, Marta Cesca, Francesca Bizzaro, Luca Porcu, Rossana Bettolini

Clin Exp Metastasis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.
Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli

Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents.
Marta Cesca, Francesca Bizzaro, Massimo Zucchetti, Raffaella Giavazzi

Front Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis